Futures are DOWN, a LOWER open expected on day #2


DOW futures are DOWN -0.03 while NASDAQ futures are also DOWN -0.03


Stock futures drop over fears of long debt battle ...

Stock-market futures pointed to a sharply lower open on Wednesday as investors grew increasingly worried about political wrangling over the budget and the potential impact on debt-ceiling negotiations.

European stock markets trade broadly lower on Wednesday. Hong Kong stocks traded higher early Wednesday, with investors returning to the market after Tuesday's closure for a national holiday. Australian stocks rose Wednesday, with modest advances while Japanese stocks swung between small gains and losses.

As for the shutdown, it looks like its hurting Republicans and helping President Obama. There is … no aggression in either direction likely means we’re range-bound in the early part of this traditionally not-range-bound month which means = treading water.


RegMed equities are looking red, if we’re going to get one of those bone-chilling fall selloffs, it’ll probably have to wait at least a few more days, or even weeks. The catalysts are few while the country’s busy debating the ineptitude of our "elected officials". But there’s no closure on Wall Street, so what’s an investor to do in the meantime?

Last night … RegMed sector stocks closed … in positive territory <23> as investors seemed to shrug off the first government shutdown since 1996.

- See more at: http://www.scimitarequity.com/articles/futures-are-down-lower-open-expected-day-2#sthash.MroNWXmU.dpuf

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Tetra Bio-Pharma completes toxicology studies on coronavirus candidate,...

Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) CEO Guy Chamberland tells Proactive it has completed toxicology studies on its coronavirus drug candidate ARDS-003, clearing the path for human clinical trials. Chamberland says next steps include structuring the applications to begin in-human...

49 minutes ago

3 min read